Junta editorial

Bishal Gyawali, MD, PhD is a medical oncologist with experience in cancer care in both low-income and high-income countries.

After graduating from medical school in Nepal with seven gold medals, he completed his postgraduate training and PhD in medical oncology at Nagoya University Graduate School of Medicine, Japan, as a MEXT scholar. Dr. Gyawali is a medical consultant at the not-for-profit Anticancer Fund, Belgium, and also holds a faculty affiliation at the Institute of Cancer Policy, London, United Kingdom. He currently works as a medical oncologist at the Civil Service Hospital, Kathmandu, Nepal.

His original research and opinion articles have been published in top oncology journals. He also provides critical commentary on oncology updates every month at his blogs on our website. He is an editorial adviser to the BMJ, and a Journal of Global Oncology Editorial Fellow for 2017 and a peer reviewer for various prestigious oncology journals. He has also delivered talks as an invited speaker at various international meetings and conferences and his video interviews have been watched over 21,000 times. His areas of clinical and research interests include cancer policy, global oncology, evidence-based oncology, financial toxicities of cancer treatment, clinical trial methods, and supportive treatments of cancer. Dr. Gyawali tweets at @oncology_bg.